RACHEL SNABES: Open Payments
NPI 1285366583 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,932 in 153 payments from 18 companies in 2025. Trend: 2023 $3,608 · 2024 $3,348 · 2025 $3,932
Food & beverage: $3,641Education: $291
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $668 |
| GENZYME CORPORATION | 15 | $374 |
| LEO Pharma Inc. | 11 | $363 |
| Galderma Laboratories, L.P. | 12 | $362 |
| Janssen Biotech, Inc. | 15 | $342 |
| Novartis Pharmaceuticals Corporation | 14 | $321 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $250 |
| E.R. Squibb & Sons, L.L.C. | 16 | $226 |
| UCB, Inc. | 6 | $201 |
| Organon LLC | 2 | $163 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, ILUMYA, Sotyktu, ANZUPGO, NEMLUVIO, Bimzelx.
Industry payments across MI — which companies pay providers there.
